Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot crossover pharmacokinetic study of Clenil Modulite with AeroChamber Plus versus Volumatic in adults with asthma
2010-022615-19Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Dec 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of beclometasone in asthma (4 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoints: B17MP AUC0-12h at steady state and B17MP Cmax at steady state. Started Dec 2010; status: completed.
02
Drugs
beclometasone
03
Conditions
asthma
Beyond the preview
Go deeper on 2010-022615-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022615-19.